Sector: Surgical & Medical Instruments & Apparatus · Industry: Medical Devices · Exchange: Nasdaq
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Headquarters: Orlando, FL, US · Employees: 150 · Website: https://www.lensar.com
LENSAR, Inc. (LNSR) is a publicly traded company in the Surgical & Medical Instruments & Apparatus sector (Medical Devices), listed on Nasdaq. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.
Competitors of LENSAR, Inc. (LNSR) tracked by Macroplane include ADVANCED MICRO DEVICES INC (AMD), Alphabet Inc. (GOOGL), Apple Inc. (AAPL), Broadcom Inc. (AVGO), CORNING INC /NY (GLW), HONEYWELL INTERNATIONAL INC (HON), INTEL CORP (INTC), JABIL INC (JBL), and 4 more.
Search companies · Macro trends · Industries · Product categories · Baskets